| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Mayo Stephen is a Director at Allogene Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $237K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 5, 2024 | SRPT Sarepta Therapeutics, Inc. | Director | Sell | 3,135 | $122.96 | $385,479.60 | -32.1% | +1.1% | -12.4% | |
| Aug 7, 2023 | ALLO Allogene Therapeutics, Inc. | Director | Sell | 10,000 | $4.29 | $42,855.00 | -28.3% | -25.6% | -40.0% | |
| Nov 17, 2022 | SRPT Sarepta Therapeutics, Inc. | Director | Sell | 858 | $109.92 | $94,311.36 | -11.8% | +13.4% | -24.4% |